Title : Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line.

Pub. Date : 2004 Mar 4

PMID : 15001986






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line. Irinotecan tumor protein p53 Homo sapiens
2 Since the DNA-damage checkpoint depends on p53 activation, the status of p53 might critically influence the response to CPT-11. Irinotecan tumor protein p53 Homo sapiens
3 Since the DNA-damage checkpoint depends on p53 activation, the status of p53 might critically influence the response to CPT-11. Irinotecan tumor protein p53 Homo sapiens
4 Activated wt-p53 increased apoptosis and enhanced sensitivity to CPT-11. Irinotecan tumor protein p53 Homo sapiens
5 We demonstrate a gain of sensitivity to CPT-11 in a p53-mutated colon cancer model either by restoring wild-type p53 function or by sequential treatment with cdk-Is. Irinotecan tumor protein p53 Homo sapiens
6 We demonstrate a gain of sensitivity to CPT-11 in a p53-mutated colon cancer model either by restoring wild-type p53 function or by sequential treatment with cdk-Is. Irinotecan tumor protein p53 Homo sapiens